Your prediction
Rm Plc. Stock
Rm Plc. shows a slight decrease today, losing -€0.010 (-0.900%) compared to yesterday.
Pros and Cons of Rm Plc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Rm Plc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Rm Plc. | -0.900% | 0.000% | 3.738% | -1.770% | -11.905% | 39.623% | -61.986% |
| Mitie Group plc | -0.830% | -0.826% | 37.143% | 49.068% | 26.984% | 107.972% | 220.000% |
| Rws Holdings plc | 1.870% | 20.360% | 50.450% | 37.732% | 33.600% | - | - |
| Mears Group plc | - | -0.794% | 5.042% | 13.250% | 21.951% | 56.250% | 133.645% |
News
Rhythm Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Rhythm Pharmaceuticals, Inc.? Here are five stocks we like better.
- IMCIVREE sales rose 19% sequentially to $71.3 million in Q2 2026, supported by early demand
